Skip to main content
. Author manuscript; available in PMC: 2014 Dec 3.
Published in final edited form as: Pacing Clin Electrophysiol. 2014 May 4;37(6):665–673. doi: 10.1111/pace.12401

Table I.

Patient Characteristics

Uninterrupted Warfarin (n = 276) Dabigatran (n = 374) Bridged (n = 232) P Value
Age (years) 62 ± 11 61 ± 12 61 ± 11 0.14
Male 178 (64.5%) 266 (71.1%) 160 (69.0%) 0.19
BMI 31 ± 6 29 ± 6 31 ± 6 0.024
Diabetes 56 (20.3%) 45 (12.0%) 39 (16.8%) 0.016
Hypertension 183 (66.3%) 214 (57.2%) 158 (68.1%) 0.010
CHF 54 (19.6%) 38 (10.2%) 27 (11.6%) 0.002
History of stroke/TIA 22 (7.9%) 39 (10.4%) 17 (7.3%) 0.49
CAD 51 (18.5%) 58 (15.5%) 48 (20.7%) 0.25
Prior MI 16 (5.8%) 16 (4.3%) 8 (3.4%) 0.43
LVEF (%) 55 ± 11 56 ± 10 55 ± 9 0.21
LA dimension (mm) 46 ± 10 45 ± 9 42 ± 6 <0.001
Type of AF 0.19
Paroxysmal 174 (63.0%) 208 (55.6%) 130 (56.0%) 0.190
Persistent 98 (35.5%) 156 (41.7%) 93 (40.1%) 0.190
Longstanding persistent 4 (1.5%) 10 (2.7%) 9 (3.9%) 0.190
CHADS2 score 1.4 ± 1.4 1.1 ± 1.1 1.2 ± 1.1 <0.001
HASBLED Score 2.1 ± 1.5 2.2 ± 1.3 2.8 ± 1.0 <0.0001

Boldface indicates statistically significance. AF = atrial fibrillation; BMI = body mass index; CAD = coronary artery disease; CHF = congestive heart failure; LA = left atrial; LVEF = left ventricular ejection fraction; MI = myocardial infarction; TIA = transient ischemic attack.